Trials / Completed
CompletedNCT01072565
Modal Day Analysis of Self Monitoring Blood Glucose Versus Continuous Glucose Monitoring
Optimization of SMBG Employing Modal Day Analysis: Examining Clinical Decision-making Processes Using Blinded FreeStyle Navigator Continuous Glucose Monitoring System (CGM)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 91 (actual)
- Sponsor
- HealthPartners Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effectiveness of Self Monitoring of Blood Glucose (SMBG) for clinical decisions related to the management of type 2 diabetes and to determine the benefit of using Continuous Glucose Monitoring (CGM) for clinical diabetes management.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | SMBG to guide clinical decisions | The investigator will base clinical decisions on A1c and modal day analysis of SMBG. |
| OTHER | SMBG and CGM | The investigator will base clinical decisions on A1c, modal day analysis of SMBG and CGM data. |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2010-02-22
- Last updated
- 2015-11-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01072565. Inclusion in this directory is not an endorsement.